Multidrug resistance gene signature in hepatocellular carcinoma with poor survival allows prediction of compounds able to convert gene expression profile to one associated with good overall survival.

Jean-Pierre Gillet; JB Andersen; Sudhir Varma; C.-P. Wu; A.M. Calcagno; S.V. Ambudkar; SS Thorgeirsson; Michael Gottesman

Multidrug resistance gene signature in hepatocellular carcinoma with poor survival allows prediction of compounds able to convert gene expression profile to one associated with good overall survival.

Jean-Pierre Gillet, JB Andersen, Sudhir Varma, C.-P. Wu, A.M. Calcagno, S.V. Ambudkar, SS Thorgeirsson, Michael Gottesman

Research output: Contribution to conference › Poster

Original language	English
Publication status	Published - 2011
Externally published	Yes
Event	AACR-NCI Conference on Systems Biology: Confronting the Complexity of Cancer - San Diego, United States Duration: 27 Feb 2011 → …

Conference

Conference	AACR-NCI Conference on Systems Biology: Confronting the Complexity of Cancer
Country/Territory	United States
City	San Diego
Period	27/02/11 → …

Cite this

Gillet, J.-P., Andersen, JB., Varma, S., Wu, C.-P., Calcagno, A. M., Ambudkar, S. V., Thorgeirsson, SS., & Gottesman, M. (2011). Multidrug resistance gene signature in hepatocellular carcinoma with poor survival allows prediction of compounds able to convert gene expression profile to one associated with good overall survival.. Poster session presented at AACR-NCI Conference on Systems Biology: Confronting the Complexity of Cancer, San Diego, United States.

Gillet, Jean-Pierre ; Andersen, JB ; Varma, Sudhir et al. / Multidrug resistance gene signature in hepatocellular carcinoma with poor survival allows prediction of compounds able to convert gene expression profile to one associated with good overall survival. Poster session presented at AACR-NCI Conference on Systems Biology: Confronting the Complexity of Cancer, San Diego, United States.

@conference{3393d69d8c47452cb70e8b9c58613a2d,

title = "Multidrug resistance gene signature in hepatocellular carcinoma with poor survival allows prediction of compounds able to convert gene expression profile to one associated with good overall survival.",

author = "Jean-Pierre Gillet and JB Andersen and Sudhir Varma and C.-P. Wu and A.M. Calcagno and S.V. Ambudkar and SS Thorgeirsson and Michael Gottesman",

year = "2011",

language = "English",

note = "AACR-NCI Conference on Systems Biology: Confronting the Complexity of Cancer ; Conference date: 27-02-2011",

}

Gillet, J-P, Andersen, JB, Varma, S, Wu, C-P, Calcagno, AM, Ambudkar, SV, Thorgeirsson, SS & Gottesman, M 2011, 'Multidrug resistance gene signature in hepatocellular carcinoma with poor survival allows prediction of compounds able to convert gene expression profile to one associated with good overall survival.', AACR-NCI Conference on Systems Biology: Confronting the Complexity of Cancer, San Diego, United States, 27/02/11.

Multidrug resistance gene signature in hepatocellular carcinoma with poor survival allows prediction of compounds able to convert gene expression profile to one associated with good overall survival. / Gillet, Jean-Pierre; Andersen, JB; Varma, Sudhir et al.
2011. Poster session presented at AACR-NCI Conference on Systems Biology: Confronting the Complexity of Cancer, San Diego, United States.

Research output: Contribution to conference › Poster

TY - CONF

T1 - Multidrug resistance gene signature in hepatocellular carcinoma with poor survival allows prediction of compounds able to convert gene expression profile to one associated with good overall survival.

AU - Gillet, Jean-Pierre

AU - Andersen, JB

AU - Varma, Sudhir

AU - Wu, C.-P.

AU - Calcagno, A.M.

AU - Ambudkar, S.V.

AU - Thorgeirsson, SS

AU - Gottesman, Michael

PY - 2011

Y1 - 2011

M3 - Poster

T2 - AACR-NCI Conference on Systems Biology: Confronting the Complexity of Cancer

Y2 - 27 February 2011

ER -

Gillet JP, Andersen JB, Varma S, Wu CP, Calcagno AM, Ambudkar SV et al.. Multidrug resistance gene signature in hepatocellular carcinoma with poor survival allows prediction of compounds able to convert gene expression profile to one associated with good overall survival.. 2011. Poster session presented at AACR-NCI Conference on Systems Biology: Confronting the Complexity of Cancer, San Diego, United States.